Pharma Excipients
Pellet
Fabrication and evaluation of fast disintegrating pellets of cilostazol
The present study was designed to formulate and develop fast disintegrating pellets of poorly soluble model drug (cilostazol) by reducing the proportion of micro-crystalline cellulose with pre-gelatinized starch (PGS), lactose and chitosan. The bioavailability enhancement of a model drug was…
Read More...
Read More...
Simulation of pellet coating in Wurster coaters
A combination of computational fluid dynamics (CFD), discrete element method (DEM), and discrete droplet method (DDM), i.e., a CFD-DEM-DDM model, was developed to simulate coating of pellets in a Wurster coater. The model equations were implemented in parallel using an approach that uses the…
Read More...
Read More...
Quantification of Swelling Characteristics of Pharmaceutical Particles
Particle swelling is a crucial component in the disintegration of a pharmaceutical tablet. The swelling of particles in a tablet creates stress inside the tablet and thereby pushes apart adjoining particles, eventually causing the tablet to break-up. This work focused on quantifying the swelling of…
Read More...
Read More...
6 reasons why to use sugar spheres
Learn more about the use of sugar spheres in this video from pharm-a-spheres™.
Sugar spheres (also called neutral pellets, nonpareil seeds, microgranules or sugar beads) are produced, preferably using a layered sugar-coating structure. The result is sugar spheres with sufficient mechanical…
Read More...
Read More...
Pharmatrans Sugar Spheres SANAQ® USP/Ph.Eur neutral pellets
Pharmatrans Sanaq’s new Sugar Spheres SANAQ® are neutral pellets made of Sucrose and maize starch that meet standards defined in the USP40-NF35, Ph. Eur and JP pharmacopoeia monographies for “Sugar Spheres”.
These white almost spherical cores with slight sweet taste can be used as a neutral basis…
Read More...
Read More...
How can oral paediatric formulations be improved? A challenge for the XXI century
Paediatric oral formulations need to be improved. This is an indisputable fact that has gain attention from the regulators, the medical staff, and researchers. The lack of adequate medicines developed for children, resulted in several off-label and unlicensed prescriptions, increasing the risks of…
Read More...
Read More...
A Biopredictive In Vitro Approach for Assessing Compatibility of a Novel Pediatric Hydrocortisone…
The objective of the present work was to screen whether a novel pediatric hydrocortisone granule formulation can be co-administered with common food matrices and liquids.
Methods
Pediatric hydrocortisone granules were studied using a biopredictive in vitro approach. Experiments included an in situ…
Read More...
Read More...
Implementation of formation mechanisms in DEM simulation of the Spheronization process of…
In the production process of pharmaceutical pellets with a narrow size distribution and a high sphericity, a combined extrusion-spheronization technique is frequently used. The rounding of the wet cylindrical extrudates in the spheronizer after the extrusion step is influenced by various interfering…
Read More...
Read More...
QbD based Eudragit coated Meclizine HCl immediate and extended release multiparticulates:…
This study is based on the QbD development of extended-release (ER) extruded-spheronized pellets of Meclizine HCl and its comparative pharmacokinetic evaluation with immediate-release (IR) pellets. HPLC-fluorescence method was developed and validated for plasma drug analysis. IR drug cores were…
Read More...
Read More...
Development of arsenic trioxide sustained-release pellets for reducing toxicity and improving…
Arsenic trioxide (ATO) is first-line drug for acute promyelocytic leukemia. Clinically, the continuously slow intravenous infusion is adopted to maintain effective blood concentration and reduce toxic effects, but it causes poor patient' compliance for a considerable infusion period. To overcome…
Read More...
Read More...